Examination of eating and nutritional habits in health care workers during the COVID-19 pandemic.

OBJECTIVES: Health care workers are in the high-risk group in terms of contracting infection because of their role in providing care to patients with COVID-19. We aim to examine the relationship between perceived stress, emotional eating, and nutritional habits in health care workers during the COVID-19 pandemic. METHODS: A cross-sectional study was conducted through an online survey in Turkey between July 1, 2021 and August 15, 2021. Overall, 405 participants age 19 to 67 y completed an online survey incorporating the Emotional Eating Scale (Cronbach's α = 0.84), Perceived Stress Scale (Cronbach's α = 0.84), and Nutrition Change Process Scale (Cronbach's α = 0.90). We gathered data on weight, height, and changes in eating habits during the pandemic to analyze how the pandemic affected dietary and nutritional practices. RESULTS: The majority of respondents were female (67.7%). Most respondents (58%) reported changing their eating and nutritional habits during the pandemic. Economic concern and concern about finding food and water due to COVID-19 were found to affect changes in eating and dietary habits (odds ratio [OR]: 2.55; 95% confidence interval [CI], 1.69-3.84; P < 0.001 and OR: 2.1; 95% CI, 1.39-3.18; P < 0.001, respectively). Losing a loved one because of COVID-19 was determined as an independent risk factor for eating and dietary habits (OR: 29.5; 95% CI, 2.23-38.9; P = 0.010). CONCLUSIONS: Perceived stress and emotional eating are related to changes in eating/dietary habits among health care workers during the pandemic. We recommend healthy food choices and increased physical activity to reduce emotional eating and mitigate stress.

The impact of personality on quality of life and disease activity in patients with Behcet's disease: a pilot study.

BACKGROUND: The aim of this study was to examine the personality characteristics of patients with Behcet's Disease (BD) using the Temperament and Character Inventory (TCI) compared with healthy control subjects and to investigate the relationship between the temperament and character properties and quality of life, disease activity, depression and anxiety in Behcet's patients. METHODS: A total of 46 BD patients and 40 healthy subjects were included in the study. All patients and controls were determined using the TCI, Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders Clinical Version for Axis I disorders (SCID-CV), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Quality of life (QOL) Instrument for Skin Disorders and Behcet Disease Current Activity Form (BDCAF). RESULTS: BD patients demonstrated significantly lower Reward Dependence than healthy controls. Among the subscales; Explarotory Excitability, Shyness with Strangers, Attachment, Spiritual Acceptance were lower and Self-Acceptance was higher in patients compared to control subjects. Decreased quality of life and increased disease activity of the patients were correlated with increased anxiety and depression. Responsibility, Self-Forgetfulness and Transpersonal Identification were associated with quality of life while Responsibility was the major factor effecting QOL. Disease activity was not found related with TCI properties. CONCLUSION: Temperament and Character traits of BD patients were different from healthy group that might be due to many factors like genetics, biological or socio-cultural differences. BD patients were demonstrated as materialistic, self-contained, self-confident, cold, detached, and reserved although they are not shy. Considering the different personality traits of BD patients in psychotherapeutic approaches, may have a positive impact on QOL and comorbid major depressive disorder.

Possible role of adrenomedullin and nitric oxide in major depression.

Adrenomedullin (ADM) and nitric oxide (NO) have been implicated in the pathogenesis of certain psychiatric disorders such as schizophrenia and bipolar disorder. ADM induces vasorelaxation by activating adenylate cyclase and stimulating the release of NO. These two molecules are known to influence cerebral activity. In this study, we aimed to examine the serum levels of ADM and NO in patients with major depression (MD). We enrolled 50 patients with MD and 50 healthy control subjects. The diagnosis of MD was established on the basis of a structured clinical interview using the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The severity of depressive symptoms was evaluated using Hamilton's 17-item Depression Rating Scale. The mean serum levels of ADM and NO in patients with MD were significantly higher than those in healthy subjects (p=0.001, for both). The severity of psychomotor retardation in patients with MD was significantly correlated with the ADM (r=0.37, p=0.007) and NO levels (r=0.29, p=0.038). The patients with obvious psychomotor retardation had significantly higher levels of ADM and NO than did the patients with no psychomotor retardation (p=0.025, p=0.030). A significantly positive correlation was found between ADM and NO levels in patients with MD (r=0.79, p=0.001). Serum levels of ADM and NO levels were not correlated with the severity or duration of depression or depressive symptoms (except psychomotor retardation). In conclusion, our study indicates that serum levels of ADM and NO are elevated in patients with MD and that increased serum levels of ADM and NO may be associated with psychomotor retardation. The ADM-NO system may serve as a new target in the treatment of patients with MD and psychomotor retardation.